CUV 1.61% $14.68 clinuvel pharmaceuticals limited

muscle mag article

  1. 648 Posts.
    Muscular Development magazine has a fairly lengthy article this month on melanotan I and melanotan II with a mention of Scenesse.

    Tanning is a top life priority for the muscle heads.

    Nothing in the article that is new, but to the author's credit, overall he did a pretty good job with the article. And he did warn about the dangers of the unregulated peptides sold on the i-Net...which surprised me given that rag has tons of ads for unproven supplements.

    The significance of the article is the media coverage, which might have some of their readers Googling 'Scenesse.'

    Not exactly the Wall Street Journal, but it's coverage anyway.


 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.